ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,675 | -11.7% | 817,574 | 0.0% | 0.01% | -28.6% |
| Q2 2023 | $1,880,420 | -24.1% | 817,574 | 0.0% | 0.01% | -22.2% |
| Q1 2023 | $2,477,249 | +129939.3% | 817,574 | 0.0% | 0.01% | +28.6% |
| Q4 2022 | $1,905 | -99.9% | 817,574 | -56.9% | 0.01% | -50.0% |
| Q3 2022 | $3,620,000 | -37.0% | 1,895,161 | -10.7% | 0.01% | -33.3% |
| Q2 2022 | $5,749,000 | -9.1% | 2,121,406 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $6,322,000 | +1776.0% | 2,121,406 | +2347.7% | 0.02% | +1700.0% |
| Q4 2021 | $337,000 | +524.1% | 86,669 | +385.5% | 0.00% | – |
| Q2 2021 | $54,000 | -61.2% | 17,851 | -59.8% | 0.00% | -100.0% |
| Q3 2020 | $139,000 | -44.2% | 44,362 | -63.0% | 0.00% | -50.0% |
| Q2 2019 | $249,000 | – | 119,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |